Company intelligence / Profile preview

IBR Inc.

Ownership: Private
Employees: ~10
Development stage: Other

Overview

IBR Inc. is a Swiss-based, GxP-compliant contract research organization (CRO) specializing in bioanalytical services for the development of biologics, biosimilars, antibodies, antibody-drug conjugates, and vaccines, covering both preclinical and clinical development phases. The company offers tailored, high-quality bioanalytical solutions, with core expertise in inflammation, cellular immunology, experimental pathology, toxicology, and pharmacokinetics. IBR Inc. emphasizes regulatory compliance, quality, and environmental responsibility, and collaborates globally to meet client needs in drug and vaccine development.

Modalities: BiologicAntibodyAntibody-drug conjugateVaccine
Industry: Contract Research Organization

Beyond the preview

Go deeper on IBR Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IBR Inc..